跳至主要内容
临床试验/NCT00712309
NCT00712309Unknown不适用

Endovascular Treatment of Atherosclerotic Popliteal Artery Lesions - Balloon Angioplasty Versus Primary Stenting

Herz-Zentrums Bad Krozingen4 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2007年2月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
250
试验地点
4
主要终点
Restenosis rate (duplex ultrasound or angiographic stenosis >50% of vascular lumen diameter; PVR > 2.4 m/s)

研究概览

简要总结

  1. Does primary stenting have a lower 12-month restenosis rate than PTA alone in the treatment of atherosclerotic lesions of the popliteal artery?
  • Alternative hypothesis: "Primary stenting with the Edwards LifeStent is associated with a lower restenosis rate than PTA alone in patients with atherosclerotic lesions of the popliteal artery at 12 months"
  • Null hypothesis: "Primary stenting with the Edwards LifeStent is not associated with a lower 12-month restenosis rate than PTA alone in patients with atherosclerotic lesions of the popliteal artery""
  1. Does comparison of the two intervention groups (PTA alone, stenting) disclose differences in terms of the secondary endpoints?
  2. How do the intervention methods compare in terms of safety/incidence of adverse effects?
  3. What are the long-term clinical implications of the two treatment methods?

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient is at least 21 years old
  • The patient or legal representative provided written informed consent
  • The patient agrees to comply with the protocol-mandated follow-up visits and testing regime
  • The patient has lifestyle-limiting claudication or critical limb ischemia defined as: Fontaine stage IIa-IV/ Rutherford 1-5 category
  • The target lesion located within the popliteal artery has angiographic evidence of stenosis > 70% or occlusion (by visual estimate)
  • At least one vessel runoff to the foot
  • The patient has no other relevant inflow or outflow stenosis (> 50%), however when needed iliac or femoral intervention may be done during study procedure.

排除标准

  • The patient is currently participating in a drug or another device study.
  • The popliteal artery target lesion has previously been subintimal recanalized
  • The patient has a history of bleeding diatheses or coagulopathy
  • Female patients that are pregnant
  • The patient has a contraindication (including allergic reaction) to platelet aggregation inhibitors or heparin
  • The patient is unable to conform to the study protocol follow-up procedures or visits.
  • The patient has a life expectancy of <24 months
  • The patient has concomitant renal failure which requires dialysis
  • The patient has a contraindication (including allergic reaction) to or a known sensitivity to contrast media
  • The duplex ultrasound/angiography of the target lesion must NOT meet the following criteria:
  • The popliteal artery target lesion stenosis/occlusion is also continuously located within the superficial femoral artery and/or tibiofibular tract
  • The popliteal artery target lesion is restenotic
  • The popliteal artery has been subintimal recanalized

结局指标

主要结局

Restenosis rate (duplex ultrasound or angiographic stenosis >50% of vascular lumen diameter; PVR > 2.4 m/s)

时间窗: 12-month

次要结局

  • Primary patency(12 and 24 months)

研究者

发起方
Herz-Zentrums Bad Krozingen
申办方类型
Other

研究点 (4)

Loading locations...

相似试验

Endovascular Treatment of Popliteal Artery - Balloon... | 临床试验